Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Scott Jones Insider Profile
4 Followers
David Scott Jones, SVP & CCO at EyePoint Pharmaceuticals, holds 44.92K shares in EyePoint Pharmaceuticals (Ticker: EYPT).
David Scott Jones EyePoint Pharmaceuticals (EYPT)SVP & CCO
EyePoint Pharmaceuticals (EYPT)
SVP & CCO
Ranked #7,366 out of 100,285 Corporate Insiders
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+68.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Scott Jones's holdings
Insider Roles
SVP & CCO
Roles that David Scott Jones holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Scott Jones
David Scott Jones's Trading History
List of latest transactions for each holding click on a transaction to see David Scott Jones's performance on stock
You May Also Like
David Scott Jones insider profile FAQ
What is the percentage of profitable transactions made by David Scott Jones?
The percentage of profitable transactions made by David Scott Jones is 100%.
What is the average return per transaction made by David Scott Jones?
The average return per transaction made by David Scott Jones is 68.00%.
What stocks does David Scott Jones hold?
David Scott Jones holds: EYPT stocks.
What was David Scott Jones’s latest transaction?
David Scott Jones latest transaction was an Uninformative Buy of $181.76K.
What was David Scott Jones's most profitable transaction?
David Scott Jones’s most profitable transaction was an Informative Sell of EYPT stock on February 5, 2024. The return on the trade was 69.90%.
What is David Scott Jones's role in EyePoint Pharmaceuticals?
David Scott Jones's role in EyePoint Pharmaceuticals is SVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.